Managing Older Adults with Ph-Negative ALL: What is New? Recent Advances in Treating Older Adults with ALL
Publication date: Available online 15 February 2021Source: Best Practice & Research Clinical HaematologyAuthor(s): Jae H. Park (Source: Best Practice and Research Clinical Haematology)
Source: Best Practice and Research Clinical Haematology - February 15, 2021 Category: Hematology Source Type: research

CAR T in Adult ALL: When and for Whom?
Publication date: Available online 13 February 2021Source: Best Practice & Research Clinical HaematologyAuthor(s): Matthew P. Connor, Noelle V. Frey (Source: Best Practice and Research Clinical Haematology)
Source: Best Practice and Research Clinical Haematology - February 14, 2021 Category: Hematology Source Type: research

Overcoming graft failure after haploidentical transplantation: Is this a possibility?
Publication date: Available online 7 February 2021Source: Best Practice & Research Clinical HaematologyAuthor(s): Xiao-Jun Huang (Source: Best Practice and Research Clinical Haematology)
Source: Best Practice and Research Clinical Haematology - February 14, 2021 Category: Hematology Source Type: research

Which Novel Agents will have a Clinically Meaningful Impact in AML at diagnosis?
Publication date: Available online 13 February 2021Source: Best Practice & Research Clinical HaematologyAuthor(s): Alexander E. Perl (Source: Best Practice and Research Clinical Haematology)
Source: Best Practice and Research Clinical Haematology - February 14, 2021 Category: Hematology Source Type: research

What are the Molecular Mechanisms Driving the Switch from MPNs to Leukemia?
Publication date: Available online 8 February 2021Source: Best Practice & Research Clinical HaematologyAuthor(s): Xiaoli Wang, Ronald Hoffman (Source: Best Practice and Research Clinical Haematology)
Source: Best Practice and Research Clinical Haematology - February 10, 2021 Category: Hematology Source Type: research

Overcoming Graft Failure after Haploidentical Transplantation: Is this a Possibility? Insights into Improving Engraftment Outcomes
Publication date: Available online 7 February 2021Source: Best Practice & Research Clinical HaematologyAuthor(s): Xiao-Jun Huang (Source: Best Practice and Research Clinical Haematology)
Source: Best Practice and Research Clinical Haematology - February 8, 2021 Category: Hematology Source Type: research

Mechanisms for Resistance in AML Insights into Molecular Pathways Mediating Resistance to Venetoclax
Publication date: Available online 6 February 2021Source: Best Practice & Research Clinical HaematologyAuthor(s): Marina Y. Konopleva (Source: Best Practice and Research Clinical Haematology)
Source: Best Practice and Research Clinical Haematology - February 7, 2021 Category: Hematology Source Type: research

Controversies in the Recent (2016) World Health Organization Classification of Acute Myeloid Leukemia
Publication date: Available online 6 February 2021Source: Best Practice & Research Clinical HaematologyAuthor(s): Robert P. Hasserjian (Source: Best Practice and Research Clinical Haematology)
Source: Best Practice and Research Clinical Haematology - February 7, 2021 Category: Hematology Source Type: research

Molecular Alterations Governing Predisposition to Myelodysplastic Syndromes: Insights from Shwachman-Diamond Syndrome
Publication date: Available online 6 February 2021Source: Best Practice & Research Clinical HaematologyAuthor(s): Akiko Shimamura (Source: Best Practice and Research Clinical Haematology)
Source: Best Practice and Research Clinical Haematology - February 7, 2021 Category: Hematology Source Type: research

Progress in the Management of chronic GVHD Insights into Novel Therapies to Treat and Manage GVHD Lasting Longer than 12 Months
Publication date: Available online 7 February 2021Source: Best Practice & Research Clinical HaematologyAuthor(s): Mary E.D. Flowers (Source: Best Practice and Research Clinical Haematology)
Source: Best Practice and Research Clinical Haematology - February 7, 2021 Category: Hematology Source Type: research

Immune checkpoint inhibitors in acute myeloid leukemia
Publication date: Available online 30 January 2021Source: Best Practice & Research Clinical HaematologyAuthor(s): Naval Daver (Source: Best Practice and Research Clinical Haematology)
Source: Best Practice and Research Clinical Haematology - February 1, 2021 Category: Hematology Source Type: research

Perspectives on Current Survival and New Developments in AML
Publication date: Available online 31 January 2021Source: Best Practice & Research Clinical HaematologyAuthor(s): Jacob M. Rowe (Source: Best Practice and Research Clinical Haematology)
Source: Best Practice and Research Clinical Haematology - February 1, 2021 Category: Hematology Source Type: research

Is there evidence for the use of FLT3 inhibitors as maintenance therapy in AML?
Publication date: Available online 28 January 2021Source: Best Practice & Research Clinical HaematologyAuthor(s): Mark Levis (Source: Best Practice and Research Clinical Haematology)
Source: Best Practice and Research Clinical Haematology - January 29, 2021 Category: Hematology Source Type: research

Why isn't there a one-size-fits-all approach for relapsed/refractory acute myeloid leukemia? Insights into different variables for decision-making
Publication date: Available online 11 January 2021Source: Best Practice & Research Clinical HaematologyAuthor(s): Ehab L. Atallah (Source: Best Practice and Research Clinical Haematology)
Source: Best Practice and Research Clinical Haematology - January 17, 2021 Category: Hematology Source Type: research

Novel Therapeutic Targets for Chronic Myelomonocytic Leukemia
Publication date: Available online 16 January 2021Source: Best Practice & Research Clinical HaematologyAuthor(s): Terra Lasho, Mrinal M. Patnaik (Source: Best Practice and Research Clinical Haematology)
Source: Best Practice and Research Clinical Haematology - January 17, 2021 Category: Hematology Source Type: research